TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

Double-Blind Phase III Trial of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer (E5103).

Kathy D Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.